Wellogix, Incorporated v. SAP America, Incorporate

648 F. App'x 398
CourtCourt of Appeals for the Fifth Circuit
DecidedMay 12, 2016
Docket15-20184, 15-20187
StatusUnpublished
Cited by20 cases

This text of 648 F. App'x 398 (Wellogix, Incorporated v. SAP America, Incorporate) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Wellogix, Incorporated v. SAP America, Incorporate, 648 F. App'x 398 (5th Cir. 2016).

Opinion

PER CURIAM: *

These consolidated appeals follow multiple lawsuits between the parties, the first of which was filed in 2008. See Wellogix, Inc. v. Accenture, LLP, 716 F.3d 867 (5th Cir.2013) (describing background of the litigation). Because of the limited scope of this decision, we do not repeat the parties’ complex dealings or litigation history. Two of the suits directly underlie the rulings before this court. One is a “Patent Case” filed by SAP in April 2010 in the Southern District of Texas seeking a declaratory judgment of non-infringement and invalidity of five Wellogix patents. The second is a “Trade Secrets Case” filed by Wellogix against SAP for theft and appropriation of trade secrets, which was intended to assert counterclaims in the Patent Case but, after some procedural jockeying, was severed and treated as a separate case.

SAP filed a summary judgment motion seeking dismissal of the severed Trade Secrets Case on several grounds, including the forum selection clause specifying Germany in the parties’ licensing agreement. The district court enforced the forum selection clause and granted dismissal for forum non conveniens with a detailed opinion. Wellogix, Inc. v. SAP Am., Inc., 58 F.Supp.3d 766 (S.D.Tex.2014). As to most aspects of the forum selection clause analysis, the court gave preclusive effect to a 2008 ruling in which another judge had dismissed SAP from the Accenture case cited above. Id. at 776, 779-80. The Trade Secrets court found that the scope of the clause had not been previously litigated, but concluded that it covered Wello-gix’s trade secrets claims because they arose “out of or in connection with” the licensing agreement and arguably depended on construction of that contract. Id. at 778. The court rejected Wellogix’s contention that SAP waived the forum selection clause by filing the Patent Case. Id. at 773-76.

Unhappy with this ruling, Wellogix filed a post-judgment motion urging, for the first time, that diversity jurisdiction, on which it had relied in filing the Trade Secrets Case, did not in fact exist because both parties are registered Delaware cor *400 porations. SAP did not challenge the facts but urged the court to uphold its dismissal order by (1) lifting its prior stay in the Patent Case, (2) rescinding the order that severed the Trade Secrets and Patent Cases, and (3) deeming the filings relating to the Trade Secrets Case to have been part of the Patent case, as an exercise of the court’s supplemental jurisdiction.

The district court essentially adopted this solution. SAP Am., Inc. v. Wellogix, Inc., Nos. H-10-1224 & H-14-741, 2015 WL 1033225 (S.D.Tex. Mar. 9, 2015). The court reasoned that its Patent Case severance order had remained interlocutory and that — as Wellogix had requested severance “without breathing any jurisdictional doubts,” and as equity disfavored giving it another chance to file claims that had twice been dismissed under the forum selection clause — Wellogix should be deemed to have consented to rescission of that order to salvage jurisdiction. Id. at *2-3. The court concluded that it could exercise supplemental jurisdiction over the state law claims because they “share a common nucleus of operative facts with the patent claims.” Id. at *4.

On appeal, Wellogix argues only that the court lacked supplemental jurisdiction over the Trade Secrets claims in the Patent Case and alternatively, that SAP waived its rights under the forum selection clause by filing the Patent Case in a U.S. federal court. Neither argument is persuasive.

1. As to the lack of subject matter jurisdiction argument, Wellogix ignores the Supreme Court’s decision that a federal court may dismiss a case on the ground of forum non conveniens without first resolving a threshold issue of jurisdiction. Sinochem Int’l Co., Ltd., v. Malay. Int’l Shipping Corp., 549 U.S. 422, 425, 127 S.Ct. 1184, 1188, 167 L.Ed.2d 15 (2007). We review the district court’s dismissal under forum non conveniens for an abuse of discretion. Ibarra v. Orica U.S.A., Inc., 493 Fed.Appx. 489, 492 (5th Cir.2012) (per curiam). Sinochem forecloses Wellogix’s argument, as the Supreme Court explicitly held that “a court need not resolve whether it has authority to adjudicate the cause (subject-matter jurisdiction) or personal jurisdiction over the defendant if it determines that, in any event, a foreign tribunal is plainly the more suitable arbiter of the merits of the case.” 549 U.S. at 425, 127 S.Ct. at 1188. And, citing Sinochem, the Second Circuit has expressly held that enforcing a forum selection clause-based dismissal is permissible before the court finally resolves its subject matter jurisdiction. See Magi XXI, Inc. v. Stato della Citta del Vaticano, 714 F.3d 714, 720 n. 6 (2d Cir.2013); see also United States ex rel. Wickliffe v. EMC Corp., 473 Fed.Appx. 849, 851-52 (10th Cir.2012) (affirming dismissal on one threshold ground without reaching district court’s alternative holding based on the first-to-file jurisdictional bar in the False Claims Act). That the dismissal here was permissible does not necessarily mean that a court is always required to consider forum non conveniens prior to subject matter jurisdiction. See Sinochem, 549 U.S. at 436, 127 S.Ct. at 1194. But we need not explore Sinochem’s nuances to conclude that the court did not abuse its discretion here. 1

2. Wellogix’s waiver argument is, if anything, weaker. In filing the Patent Case, SAP’s complaint included a section titled “Specific Relief Not Requested,” which stated: “SAP does not request any additional relief with respect to the claims adjudicated in this Court’s Order of December 8, 2008 beyond that which has *401 already been granted to SAP, all such claims being separate and distinct from the non-infringement and invalidity of the Wellogix Patents.” 2 Wellogix does not deny that the forum selection clause requiring suits to be litigated in Germany is valid and covers the disputes embodied in the Trade Secrets Case, nor does it contest any other aspect of the court’s forum non conveniens ruling.

There is a lack of authority determining whether federal or state law principles control the standard for determining a party’s waiver of rights under a forum selection clause. The district court reviewed the waiver issues under both regimes, federal and Texas law.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
648 F. App'x 398, Counsel Stack Legal Research, https://law.counselstack.com/opinion/wellogix-incorporated-v-sap-america-incorporate-ca5-2016.